| Year |
Citation |
Score |
| 2011 |
Huang B, Deora AB, He KL, Chen K, Sui G, Jacovina AT, Almeida D, Hong P, Burgman P, Hajjar KA. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood. 118: 2918-29. PMID 21788340 DOI: 10.1182/Blood-2011-03-341214 |
0.636 |
|
| 2009 |
Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD, Hajjar KA. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. The Journal of Clinical Investigation. 119: 3384-94. PMID 19841537 DOI: 10.1172/Jci39591 |
0.615 |
|
| 2009 |
Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, Papalardo E, Vargas G, Deora AB, Wang M, Jacovina AT, Garcia-Latorre E, Reyes-Maldonado E, Hajjar KA, Pierangeli SS. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood. 114: 3074-83. PMID 19628708 DOI: 10.1182/Blood-2008-11-188698 |
0.592 |
|
| 2004 |
Deora AB, Kreitzer G, Jacovina AT, Hajjar KA. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface Journal of Biological Chemistry. 279: 43411-43418. PMID 15302870 DOI: 10.1074/Jbc.M408078200 |
0.602 |
|
| 2004 |
Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, Hempstead B, Mark WH, Hajjar KA. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. The Journal of Clinical Investigation. 113: 38-48. PMID 14702107 DOI: 10.1172/Jci19684 |
0.681 |
|
| 2004 |
Brownstein C, Deora AB, Jacovina AT, Weintraub R, Gertler M, Khan KM, Falcone DJ, Hajjar KA. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood. 103: 317-24. PMID 14504107 DOI: 10.1182/Blood-2003-04-1304 |
0.653 |
|
| 2002 |
Arzimanoglou II, Hansen LL, Chong D, Li Z, Psaroudi MC, Dimitrakakis C, Jacovina AT, Shevchuk M, Reid L, Hajjar KA, Vassilaros S, Michalas S, Gilbert F, Chervenak FA, Barber HR. Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Research. 22: 969-75. PMID 12014680 |
0.455 |
|
| 2001 |
Brownstein C, Falcone DJ, Jacovina A, Hajjar KA. A mediator of cell surface-specific plasmin generation Annals of the New York Academy of Sciences. 947: 143-156. PMID 11795262 DOI: 10.1111/J.1749-6632.2001.Tb03937.X |
0.65 |
|
| 2001 |
Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. The Journal of Biological Chemistry. 276: 49350-8. PMID 11679580 DOI: 10.1074/Jbc.M106289200 |
0.642 |
|
| 1999 |
Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. The New England Journal of Medicine. 340: 994-1004. PMID 10099141 DOI: 10.1056/Nejm199904013401303 |
0.549 |
|
| 1998 |
Hajjar KA, Jacovina AT. Modulation of annexin II by homocysteine: implications for atherothrombosis. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 46: 364-9. PMID 9805420 |
0.649 |
|
| 1998 |
Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. The Journal of Biological Chemistry. 273: 9987-93. PMID 9545344 DOI: 10.1074/Jbc.273.16.9987 |
0.635 |
|
| 1996 |
Lander HM, Jacovina AT, Davis RJ, Tauras JM. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. The Journal of Biological Chemistry. 271: 19705-9. PMID 8702674 DOI: 10.1074/Jbc.271.33.19705 |
0.306 |
|
| 1994 |
Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. The Journal of Biological Chemistry. 269: 21191-7. PMID 8063740 |
0.647 |
|
| Show low-probability matches. |